Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-25 @ 9:34 PM
Study NCT ID:
NCT06136351
Status:
RECRUITING
Last Update Posted:
2023-11-29
First Post:
2023-09-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma
Sponsor:
Ruijin Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-15
Start Date Type:
ACTUAL
Primary Completion Date:
2027-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-25
First Submit QC Date:
None
Study First Post Date:
2023-11-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-24
Last Update Post Date:
2023-11-29
Last Update Post Date Type:
ACTUAL